|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07D 209/34 | (2006.01) |
| A61K 31/404 | (2006.01) | ||
| A61P 35/04 | (2006.01) |
| (11) | Number of the document | 1527047 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03766212.9 |
| Date of filing the European patent application | 2003-07-18 | |
| (97) | Date of publication of the European application | 2005-05-04 |
| (45) | Date of publication and mention of the grant of the patent | 2012-03-28 |
| (46) | Date of publication of the claims translation | 2012-07-25 |
| (86) | Number | PCT/EP2003/007822 |
| Date | 2003-07-18 |
| (87) | Number | WO 2004/013099 |
| Date | 2004-02-12 |
| (30) | Number | Date | Country code |
| 10233500 | 2002-07-24 | DE |
| (72) |
ROTH, Gerald, Jürgen, DE
SIEGER, Peter, DE
LINZ, Guenter, DE
RALL, Werner, DE
HILBERG, Frank, AT
BOCK, Thomas, DK
|
| (73) |
Boehringer Ingelheim Pharma GmbH & Co. KG,
55216 Ingelheim am Rhein,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | 3-Z- 1-(4-(N-((4-metil-piperazin-1-il)metilkarbonil)-N-metil-amino)-anilin)-1-fenil-metilen-6-metoksikarbonil-2-indolinon-monoetansulfonatas ir jo panaudojimas kaip farmacinės kompozicijos |
| 3-Z- 1-(4-(N-((4-METHYL-PIPERAZIN-1-YL)-METHYLCARBONYL)-N-ME THYL-AMINO)-ANILINO)-1-PHENYL-METHYLENE -6-METHOXYCARBONYL-2 -INDOLINONE-MONOETHANESULPHONATE AND THE USE THEREOF AS A PHARMACEUTICAL COMPOSITION |
| Payment date | Validity (years) | Amount | |
| 2022-06-23 | 347.00 EUR |